Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.32	34.49	128.1	60.2	142.44
Short-Term Investments	3.87	7.53	6.2	5.91	7.85
Trading Asset Securities	53.33	1.54	16.16	33.76	111.96
Cash & Short-Term Investments	73.51	43.56	150.45	99.87	262.24
Cash Growth	68.75%	-71.05%	50.65%	-61.92%	27.47%
Accounts Receivable	22.28	27.14	41.45	66.29	58.69
Other Receivables	27.28	27.28	26.49	26.13	10.35
Receivables	64.8	96.97	131.96	132.46	170.66
Inventory	24.59	15.25	35.61	32.77	33.74
Prepaid Expenses	4.21	2.87	3.99	3.12	1.87
Other Current Assets	6.94	3.83	-	-	-
Total Current Assets	174.05	162.48	322.01	268.22	468.51
Property, Plant & Equipment	280.18	310.63	381.28	435.95	172.2
Long-Term Investments	95.9	134.03	184.13	318.94	320.69
Goodwill	-	-	-	-	0.51
Other Intangible Assets	-	-	0.28	0.66	7.73
Long-Term Deferred Charges	-	-	-	0.97	2.31
Total Assets	550.32	607.34	887.7	1,025	971.94
Accounts Payable	12.53	17.96	28.32	37.88	29.97
Accrued Expenses	18.89	16.91	15.49	12.15	13.89
Short-Term Debt	99.36	94.39	295.35	388.87	186.95
Current Portion of Long-Term Debt	339.32	164.89	-	-	112.23
Current Portion of Leases	10.13	14.46	12	14.41	14.25
Current Income Taxes Payable	0.17	0.51	4.14	2.17	4.49
Current Unearned Revenue	22.16	18.88	17.18	23.48	28.08
Other Current Liabilities	55.44	52.7	37.51	50.61	17.62
Total Current Liabilities	557.98	380.71	410	529.56	407.48
Long-Term Debt	26.81	191.45	191.29	-	-
Long-Term Leases	6.17	14.1	2.9	8.12	8.09
Total Liabilities	590.96	586.27	604.19	537.68	415.57
Common Stock	112.24	112.24	112.24	112.24	110.95
Additional Paid-In Capital	1,908	1,908	1,908	1,908	1,876
Retained Earnings	-2,137	-2,061	-1,801	-1,608	-1,539
Comprehensive Income & Other	34.07	39.92	45.27	58.52	40.05
Total Common Equity	-83.2	-0.85	263.96	469.92	488.04
Minority Interest	42.56	21.92	19.55	17.13	68.33
Shareholders' Equity	-40.64	21.07	283.51	487.05	556.37
Total Liabilities & Equity	550.32	607.34	887.7	1,025	971.94
Total Debt	481.78	479.3	501.55	411.41	321.52
Net Cash (Debt)	-408.27	-435.74	-351.1	-311.54	-59.28
Net Cash Per Share	-0.15	-0.16	-0.13	-0.11	-0.02
Filing Date Shares Outstanding	2,806	2,806	2,806	2,806	2,774
Total Common Shares Outstanding	2,806	2,806	2,806	2,806	2,774
Working Capital	-383.93	-218.23	-87.99	-261.34	61.03
Book Value Per Share	-0.03	-0.00	0.09	0.17	0.18
Tangible Book Value	-83.2	-0.85	263.68	469.26	479.81
Tangible Book Value Per Share	-0.03	-0.00	0.09	0.17	0.17
Buildings	175.81	174.32	167.34	-	-
Machinery	169.74	175.68	175.55	77.24	75.06
Construction In Progress	2.4	5.81	0.65	310.85	133.08
Leasehold Improvements	5.19	5.41	5.33	5.37	5.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.